Eagle Asset Management Inc Aldeyra Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 709,518 shares of ALDX stock, worth $3.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

709,518

Previous 841,571 15.69%

Holding current value

$3.46 Million

Previous $2.79 Million 37.31%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.19 - $6.32 $421,249 - $834,574	-132,053 Reduced 15.69%	709,518 $3.82 Million
Q2 2024 Aug 12, 2024	SELL	$3.25 - $4.72 $410,293 - $595,871	-126,244 Reduced 13.04%	841,571 $2.79 Million
Q1 2024 May 09, 2024	SELL	$2.77 - $4.22 $117,777 - $179,430	-42,519 Reduced 4.21%	967,815 $3.16 Million
Q4 2023 Feb 12, 2024	SELL	$1.47 - $6.06 $47,129 - $194,289	-32,061 Reduced 3.08%	1,010,334 $3.55 Million
Q3 2023 Nov 13, 2023	SELL	$6.11 - $8.16 $98,682 - $131,792	-16,151 Reduced 1.53%	1,042,395 $6.96 Million
Q2 2023 Aug 09, 2023	SELL	$7.11 - $11.89 $5.58 Million - $9.34 Million	-785,464 Reduced 42.6%	1,058,546 $8.88 Million
Q1 2023 May 08, 2023	BUY	$5.77 - $9.93 $417,292 - $718,147	72,321 Added 4.08%	1,844,010 $18.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $1.59 Million - $2.22 Million	313,681 Added 21.51%	1,771,689 $12.3 Million
Q3 2022 Nov 07, 2022	SELL	$3.8 - $7.74 $182,134 - $370,978	-47,930 Reduced 3.18%	1,458,008 $7.79 Million
Q2 2022 Aug 10, 2022	BUY	$2.43 - $4.85 $78,923 - $157,523	32,479 Added 2.2%	1,505,938 $6.01 Million
Q1 2022 May 12, 2022	BUY	$3.25 - $5.17 $261,699 - $416,303	80,523 Added 5.78%	1,473,459 $6.55 Million
Q4 2021 Feb 11, 2022	BUY	$3.5 - $9.63 $162,638 - $447,486	46,468 Added 3.45%	1,392,936 $5.66 Million
Q3 2021 Nov 10, 2021	BUY	$7.94 - $11.31 $2.07 Million - $2.95 Million	260,950 Added 24.04%	1,346,468 $11.8 Million
Q2 2021 Aug 11, 2021	BUY	$10.44 - $14.85 $11.3 Million - $16.1 Million	1,085,518 New	1,085,518 $12.3 Million

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $285M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Aldeyra Therapeutics, Inc. Transaction History